Written question asked by Paul Burstow (Liberal Democrat) on Tuesday, 10 March 2015, in the House of Commons. It was due for an answer on Thursday, 12 March 2015. It was answered by George Freeman (Conservative) on Tuesday, 17 March 2015 on behalf of the Department of Health.
Co-careldopa
- Question
-
To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224941, what the precise recommendation made by the Clinical Reference Group referred to in that Answer was; whether that recommendation related to (a) in year or (b) ongoing routine commissioning; and if he will make a statement.
- Answer
-
NHS England has advised that its Neuroscience Clinical Reference Group’s recommendation was to approve the clinical policy to support the routine commissioning of levodopa-carpidopa intestinal gel for advanced Parkinson’s disease and to go out to full public consultation.
The recommendation related to an in year commissioning decision.
Secondary information
- Type
- Written question
- Reference
- 227005
- Session
- 2014-15
- Related items
- Subjects
- Co-careldopa
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2024-05-29 09:07:58 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227005
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227005
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/227005